Procter & Gamble will acquire the supplements maker Thorne for $3.8 billion [1] in cash [2].
The deal signals a major strategic pivot for the consumer goods giant as it seeks to capture the growing market for self-care and personalized health products. By absorbing Thorne, P&G integrates a specialized wellness brand into its broader corporate ecosystem to meet shifting consumer preferences.
CEO Shailesh Jejurikar said the acquisition was announced Tuesday, Aug. 4 [1]. The purchase involves the acquisition of Thorne from L Catterton, a private-equity firm backed by LVMH [1].
P&G said the move is designed to grow its health and wellness business. The company is targeting a rise in demand for high-quality supplements and wellness tools that allow consumers to take more direct control of their health outcomes [1].
The transaction is structured as an all-cash deal [2]. This financial move allows P&G to quickly scale its presence in the supplement sector without the complexities of a stock swap or prolonged merger negotiations.
Thorne has established itself as a premium provider in the supplement space. The acquisition allows P&G to leverage Thorne's existing brand equity and distribution channels to reach a more health-conscious demographic, a segment that has seen consistent growth in recent years [1].
“Procter & Gamble will acquire the supplements maker Thorne for $3.8 billion in cash.”
This acquisition demonstrates a broader trend of traditional consumer packaged goods companies diversifying into 'science-backed' wellness. By spending $3.8 billion on a specialized brand like Thorne, P&G is moving beyond general hygiene and beauty into the more lucrative and complex territory of nutritional science and preventative health.
